Please fill in the weight loss consultation below

1

cm
Value must be between 100cm and 220cm
2

kg
Value must be between 40kg and 250kg
3

4

5

  • Prediabetes
  • Type 2 diabetes
  • High blood pressure
  • High cholesterol
  • Heart or blood vessel disease (including previous heart attack)
  • History of stroke
  • Obstructive sleep apnoea Osteoarthritis Metabolic dysfunction associated steatotic liver disease (MASLD) (formerly fatty liver disease)
  • Polycystic ovary syndrome (PCOS) or infertility

6

7

 Pregnant ,Breastfeeding or Planning to become pregnant

 

GLP-1 medications (such as Mounjaro and Wegovy) are not recommended for use during pregnancy or while breastfeeding.

8

  • Pancreatitis
  • Liver cirrhosis or received a liver transplant
  • Any cancer under active specialist treatment
  • Eye disease due to diabetes (retinopathy)
  • Heart failure with shortness of breath at rest
  • Chronic kidney disease (eGFR < 30)
  • Chronic digestive issues (e.g., Crohn’s, ulcerative colitis, gastroparesis)
  • Treatment for alcohol dependency
  • Malabsorption syndromes (problems
  • Endocrine disorders (Overactive thyroid awaiting radioactive iodine or surgery, Addison’s disease,acromegaly, Cushing’s syndrome, congenital adrenal hyperplasia, or a growth hormone disorder, etc.)
  • Cognitive or memory impairments (e.g., dementia)

9

  • Gallstones (not removed)
  • Blocked bile flow (cholelithiasis)
  • Gallbladder infection (cholecystitis)
  • Gallbladder surgery within the last 12 months

10

  • Sleeve gastrectomy (gastric sleeve)
  • Gastric bypass (Roux-en-Y)
  • Endoscopic sleeve gastroplasty
  • Gastric balloon
  • Biliopancreatic diversion or duodenal bypass

11

If you suspect you may have an eating disorder — even if you’ve never received a formal diagnosis — please answer ‘yes.’ Being honest is important for ensuring your health and safety.

12

If so, please let us know. GLP-1 medications can impact insulin needs and blood sugar control, and should only be used by individuals with type 1 diabetes under the supervision of a specialist diabetes care team.

13

14

15

  • Amiodarone
  • Carbamazepine
  • Ciclosporin
  • Clozapine
  • Digoxin
  • Fenfluramine
  • Lithium
  • Mycophenolate mofetil
  • Oral methotrexate
  • Phenobarbital
  • Phenytoin
  • Somatrogon
  • Tacrolimus
  • Theophylline
  • Warfarin

16

17

18

(This can be from eMeds or another provider)

19

Do you understand that you may be asked to provide proof of a prescription from another provider if either of the following applies:

●       This is your first order of injectable weight-loss medication from eMeds and you are not requesting the starter dose.

 

●       Your last order from Emeds was more than 6 months ago, and you have been receiving treatment from another provider since then.

20

Thoughts of self-harm or suicide, depression, anxiety, or mood disorder

21

22

If you experience severe abdominal pain (especially if it radiates to your back), vomiting, or worsening symptoms, seek urgent medical attention by calling 999 or going to A&E.

Do you understand and agree?

23

You should use an additional method of contraception (e.g. condoms, IUD, or implant) to prevent unplanned pregnancy while taking Mounjaro. Do you understand and agree?

24

You may need to take an additional dose and should call 111 for medical advice to avoid unplanned pregnancy.

Do you understand and agree?

25

Do you understand and agree?

26

If you experience low mood, suicidal thoughts, thoughts of self-harm, or other concerning mental health symptoms, you should stop treatment and seek medical advice from your GP or mental health team.

Do you understand and agree?

27

●       The information I have provided is true and accurate to the best of my knowledge.

●       This information will be used by eMeds prescribers to assess whether treatment is suitable for me.

●       I understand that providing inaccurate or incomplete information may result in being refused treatment or being prescribed medication that is not appropriate.

28

●       This treatment is solely for my own personal use.

●       I will read the patient information leaflet supplied with the medication.

●       I will contact eMeds and inform my GP if I experience any side effects, begin new medications, or if my health status changes during treatment.

●       I give consent for Emeds to notify my GP that I am using GLP-1 weight-loss medication and to allow my GP to share relevant information with Emeds if necessary.

●       I give permission for Emeds to access additional medical information from my GP via Summary Care Records., if required.

●       I consent to the collection, processing, and secure storage of my personal and health information for the purpose of evaluating and managing my treatment.

●       I understand that my information may be shared with relevant healthcare professionals for the purpose of my care.

●    I understand that I can withdraw my consent at any time and will be provided with guidance on how to do so.

29

30

31

32

Please complete all required questions.